AstraZeneca to hike 2024 dividend by 7%
11th Apr 2024 07:20
(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.
Read moreAstraZeneca's Enhurtu cancer gets US green light for adult patients
8th Apr 2024 07:02
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.
Read moreAstraZeneca announces positive lung cancer treatment trial results
5th Apr 2024 07:23
(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.
Read moreLondon close: Stocks turn red on return from Easter break
2nd Apr 2024 15:22
(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.
Read moreUS FDA gives green light for use of AstraZeneca's Voydeva
2nd Apr 2024 07:08
(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).
Read moreAstraZeneca gets FDA approval for Ultomiris treatment
25th Mar 2024 07:23
(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.
Read moreAstraZeneca to buy US-listed Fusion Phrama for $2bn
19th Mar 2024 07:05
(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.
Read moreAstraZeneca snaps up rare disease specialist Amolyt for $1.05bn
14th Mar 2024 07:16
(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.
Read moreAstraZeneca's chemo replacement treatment moves closer to EU approval
4th Mar 2024 07:18
(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.
Read moreAstraZeneca's blood-disorder drug recommended for EU approval
26th Feb 2024 07:22
(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.
Read moreAstraZeneca acquires US-based biopharmaceutical company
20th Feb 2024 10:29
(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.
Read moreLondon close: Stocks manage gains on globally quiet day
19th Feb 2024 15:59
(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.
Read moreAstraZeneca's Tagrisso gains FDA approval
19th Feb 2024 08:03
(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.
Read moreBarclays sees "compelling" entry point at AstraZeneca after recent falls
12th Feb 2024 09:12
(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.
Read moreLondon close: Stocks slip as US jobless claims fall
8th Feb 2024 14:42
(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.
Read more